COST-UTILITY ANALYSIS OF ROPINIROLE IN PARKINSON'S DISEASE (PD) TREATMENT

被引：0
|
作者：
Zerda, I [1 ]
Drozdz, A. [1 ]
Brzyski, D. [1 ]
Pochopien, M. [1 ]
Gwiosda, B. [1 ]
Lisiecka, B. [1 ]
Barlog, D. [2 ]
Glogowski, C. [2 ]
Dziurda, D. [2 ]
Rys, P. [1 ]
Plisko, R. [1 ]
机构：
[1] HTA Consulting, Krakow, Poland
[2] GSK, Warsaw, Poland
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.498
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A323 / A323
页数：1
相关论文
共 50 条
  • [1] Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's disease
    Iskedjian, M
    Einarson, TR
    [J]. PHARMACOECONOMICS, 2003, 21 (02) : 115 - 127
  • [2] Cost Analysis of Ropinirole versus Levodopa in the Treatment of Parkinson’s Disease
    Michael Iskedjian
    Thomas R. Einarson
    [J]. PharmacoEconomics, 2003, 21 : 115 - 127
  • [3] Cost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland
    Hudry, J
    Rinne, JO
    Keränen, T
    Eckert, L
    Cochran, JM
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 651 - 657
  • [4] ADAPTATION OF A COST-UTILITY MODEL OF RASAGILINE IN THE TREATMENT OF PARKINSON'S DISEASE IN CHINA
    Chen, S.
    Chen, H.
    Zhang, B.
    Shang, H.
    Tan, K. H.
    Ma, F.
    Dorey, J.
    Le Lay, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S94 - S94
  • [5] Treatment of Advanced Parkinson’s Disease in the United StatesA Cost-Utility Model
    Huybert Groenendaal
    Marcy L. Tarrants
    Christophe Armand
    [J]. Clinical Drug Investigation, 2010, 30 : 789 - 798
  • [6] TREATMENT OF ADVANCED PARKINSON'S DISEASE IN THE UNITED STATES: A COST-UTILITY MODEL
    Tarrants, M. L.
    Groenendaal, H.
    Armand, C.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A370 - A370
  • [7] Treatment costs in Hodgkin's disease: A cost-utility analysis
    Norum, J
    Angelsen, V
    Wist, E
    Olsen, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1510 - 1517
  • [8] Treatment of Advanced Parkinson's Disease in the United States A Cost-Utility Model
    Groenendaal, Huybert
    Tarrants, Marcy L.
    Armand, Christophe
    [J]. CLINICAL DRUG INVESTIGATION, 2010, 30 (11) : 789 - 798
  • [9] Treatment of advanced Parkinson's disease in the United States: a cost-utility model
    Tarrants, M.
    Groenendaal, H.
    Armand, C.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S135 - S136
  • [10] COST-UTILITY ANALYSIS OF DONEPEZIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE IN THAILAND
    Permsuwan, U.
    Niwatananun, W.
    Pimkrai, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A648 - A648
12345